13,14-Dihydro-15-keto-PGE1
Product Specifications
UNSPSC Description
13,14-Dihydro-15-keto-PGE1 is an inactive metabolite of PGE1. 13, 14-Dihydro-15-Keto-pGE1 inhibited platelet aggregation in ADP-induced human isolated platelet-rich plasma with IC50 14.8 μg/mL[1].
Target Antigen
Drug Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Endocrinology
Assay Protocol
https://www.medchemexpress.com/13-14-dihydro-15-keto-pge1.html
Solubility
10 mM in DMSO
Smiles
OC(CCCCCC[C@@H]1[C@H]([C@@H](CC1=O)O)CCC(CCCCC)=O)=O
Molecular Weight
354.48
References & Citations
[1]Katzenschlager R, et al. Synergism between PGE1-metabolites(13,14-dihydro-prostaglandin E1, 15-keto prostaglandin E1, 15-keto-13,14-dihydro-prostaglandin E1) and nitric oxide (NO) on platelet aggregation. Prostaglandins Leukot Essent Fatty Acids. 1992 Mar;45(3):207-10.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-137591/13-14-Dihydro-15-keto-PGE1-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-137591/
Clinical Information
No Development Reported
CAS Number
5094-14-4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
